Profile
Brett Angel has founded Sonnest, Inc. in 2019 and currently holds the title of Chief Medical Officer.
Brett Angel active positions
| Companies | Position | Start |
|---|---|---|
Sonnest, Inc.
 Sonnest, Inc. Medical SpecialtiesHealth Technology Sonnest, Inc. is a company that specializes in developing a contrast agent called Electrast™. The company is based in Baltimore, MD. The inspiration for Electrast™ began in 2015 through a collaboration between Dr. Wrenn, the company's Chief Scientific Officer, and Dr. Brett Angel, an electrophysiologist at Drexel University. Electrast™ is a voltage-activated ultrasound contrast agent that activates with ultrasound and the heart's local electric field if the heart tissue is perfused and viable. The company was founded in 2019 by Steve Wrenn, Brett Angel. The CEO is Peter Boyd. | Founder | 01/01/2019 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Sonnest, Inc.
Sonnest, Inc. Medical SpecialtiesHealth Technology Sonnest, Inc. is a company that specializes in developing a contrast agent called Electrast™. The company is based in Baltimore, MD. The inspiration for Electrast™ began in 2015 through a collaboration between Dr. Wrenn, the company's Chief Scientific Officer, and Dr. Brett Angel, an electrophysiologist at Drexel University. Electrast™ is a voltage-activated ultrasound contrast agent that activates with ultrasound and the heart's local electric field if the heart tissue is perfused and viable. The company was founded in 2019 by Steve Wrenn, Brett Angel. The CEO is Peter Boyd. | Health Technology |
- Stock Market
- Insiders
- Brett Angel
